JLB & Associates’s Core Laboratories CLB Stock Holding History

JLB & Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$437K	Sell	3,646 -2,945	-45%	-$326K	0.12%	72
2016 Q3	$740K	Sell	6,591 -10,282	-61%	-$1.18M	0.2%	64
2016 Q2	$2.09M	Buy	+16,873	New	+$2.04M	0.59%	50
2016 Q1	–	Sell	-18,480	Closed	-$2.01M	–	75
2015 Q4	$2.01M	Sell	18,480 -2,920	-14%	-$334K	0.62%	48
2015 Q3	$2.13M	Sell	21,400 -263	-1%	-$28.6K	0.69%	48
2015 Q2	$2.47M	Buy	21,663 +840	+4%	+$102K	0.77%	46
2015 Q1	$2.17M	Buy	20,823 +2,429	+13%	+$259K	0.68%	48
2014 Q4	$2.21M	Sell	18,394 -4,291	-19%	-$564K	0.74%	45
2014 Q3	$3.32M	Buy	22,685 +677	+3%	+$105K	1.19%	38
2014 Q2	$3.68M	Buy	22,008 +7,461	+51%	+$1.33M	1.33%	33
2014 Q1	$2.89M	Buy	14,547 +11,313	+350%	+$2.14M	1.08%	37
2013 Q4	$617K	Buy	3,234 +939	+41%	+$175K	0.24%	67
2013 Q3	$388K	Buy	+2,295	New	+$356K	0.16%	67

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JLB & Associates's CLB Position: Q4 2016 in Review

JLB & Associates reduced its Core Laboratories (CLB) stake by 45% in Q4 2016, selling an estimated $326K and leaving 3,646 shares worth $437K. The position accounts for 0.12% of the portfolio, ranked #72.

JLB & Associates first reported a position in CLB in Q3 2013 and has held it in 13 quarters since. The position peaked at $3.68M in Q2 2014. 373 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

JLB & Associates held 3,646 shares of Core Laboratories worth $437K as of Q4 2016.
JLB & Associates sold 2,945 Core Laboratories shares in Q4 2016, an estimated $326K.
Core Laboratories made up 0.12% of JLB & Associates's portfolio in Q4 2016, its #72 holding.
JLB & Associates first reported a position in Core Laboratories in Q3 2013 and has held it in 13 quarters since.
JLB & Associates's Core Laboratories position peaked at $3.68M in Q2 2014.
373 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on JLB & Associates's 13F filing for Q4 2016, filed 18 Jan 2017.